The National Drug Code (NDC) for Miebo (perfluorohexyloctane ophthalmic solution) 3 mL is 43741-103-03 [1].
What is Miebo used for?
Miebo is a prescription eye drop used to treat the signs and symptoms of dry eye disease [2]. It works by reducing evaporation of tear film, which helps to stabilize the tear film and reduce dryness [3].
How does Miebo work?
Miebo is a unique ophthalmic solution that consists of perfluorohexyloctane. This ingredient forms a lipid layer on the surface of the eye, which helps to prevent rapid evaporation of the tear film. By reducing evaporation, Miebo supports the natural tear film and alleviates the symptoms associated with dry eye disease [3].
What are the side effects of Miebo?
Common side effects of Miebo include temporary blurred vision immediately after application and eye irritation [2]. Patients are advised to avoid touching the dropper tip to the eye or any surface to prevent contamination [4].
When does Miebo's patent expire?
The patent expiry for Miebo is a complex area influenced by various factors, including potential exclusivities and the specific patents held by the manufacturer, Bausch + Lomb. DrugPatentWatch.com tracks patent information for numerous drugs, which can provide insights into potential market entry for generics [5]. General information on drug patent cliffs and the exclusivity periods that can extend beyond patent expiry is available through resources like DrugPatentWatch.com [5].
Can generic versions of Miebo be developed?
The development and approval of generic versions of Miebo would typically occur after the expiration of relevant patents and any applicable market exclusivities. Regulatory bodies like the U.S. Food and Drug Administration (FDA) review generic drug applications to ensure they are bioequivalent to the brand-name product. Information regarding potential generic competition and timelines can often be found by tracking patent expirations and exclusivities [5].
What is the recommended dosage for Miebo?
The recommended dosage for Miebo is one drop instilled in each affected eye twice daily [2].
What are the alternatives to Miebo for dry eye disease?
Besides Miebo, other treatments for dry eye disease include artificial tears, prescription eye drops like cyclosporine (Restasis) or lifitegrast (Xiidra), punctal plugs, and lifestyle modifications such as using a humidifier or taking breaks from screens [6]. The best treatment option depends on the individual's specific condition and severity of symptoms.
How does Miebo compare to other dry eye treatments?
Miebo's mechanism of action, which focuses on reducing tear evaporation through a lipid layer, differentiates it from some other dry eye treatments that primarily aim to increase tear production or lubricate the eye. Treatments like artificial tears provide temporary lubrication, while prescription drops like Restasis and Xiidra work to reduce inflammation and increase natural tear production over time [6].
Where can I find more information on Miebo?
For more detailed information on Miebo, including prescribing information and patient resources, consult the official product website or your healthcare provider. Information on drug patents and potential generic market entry can be found on sites like DrugPatentWatch.com [5].
---
Sources
1. https://www.drugs.com/nda/miebo-230002.html
2. https://www.miebo.com/
3. https://www.bausch.com/our-products/miebo/
4. https://www.rxlist.com/miebo-side-effects-drug-center.htm
5. https://drugpatentwatch.com/
6. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/dry-eye/treatment-dry-eye